Central nervous system toxicity related to FK506 in patients with Behçet's disease.
Open Access
- 1 May 1994
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 53 (5) , 350-351
- https://doi.org/10.1136/ard.53.5.350
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Vasculitis in patients with systemic sclerosis and severe digital ischaemia requiring amputation.Annals of the Rheumatic Diseases, 1994
- A multicenter clinical open trial of FK 506 in refractory uveitis, including Behçet's disease. Japanese FK 506 Study Group on Refractory Uveitis.1991
- Autoimmunity after Alpha-Interferon Therapy for Malignant Carcinoid TumorsAnnals of Internal Medicine, 1991
- Scleroderma and central nervous system vasculitis.Stroke, 1991
- Mechanism of action of FK 506 and cyclosporinThe Lancet, 1991
- EFFECTS OF A NEW IMMUNOSUPPRESSIVE AGENT, FK506, ON EXPERIMENTAL AUTOIMMUNE UVEORETINITIS IN RATS1988
- Cerebral arteritis in scleroderma.Stroke, 1979
- Acute Neurological Complications After Liver Transplantation with Particular Reference to Intraoperative Cerebral Air EmbolusAnnals of Surgery, 1978
- Carotid arteritis and cerebral infarction due to sclerodermaNeurology, 1967